Auscann Group Holdings Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Auscann Group Holdings Ltd with three other
pharmaceutical manufacturers in Australasia:
sales of 956,472.00 Australian Dollars [US$645,829.02 ]
Anatara Lifesciences Ltd
(842,547.00 Australian Dollars [US$568,904.59 ]
MGC Pharmaceuticals Ltd
(858,087.00 Australian Dollars [US$579,397.50 ]
Sales increased substantially in 2019:
Auscann Group Holdings Ltd reported sales of A$861,770.00 (US$581.88 thousand)
June of 2019.
increase of 266.6%
versus 2018, when the company's sales were A$235,064.00 .
This was the third consecutive year of growth at Auscann Group Holdings Ltd.